Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet‐activating factor receptor
暂无分享,去创建一个
J. Miyazaki | F. Tashiro | Takao Shimizu | K. Kume | K. Ikuta | T. Nagase | I. Waga | Sayuri Sato | S. Ishii
[1] T. Ahmed,et al. Inhibition of antigen-induced airway hyperresponsiveness by ultralow molecular-weight heparin. , 1998, American journal of respiratory and critical care medicine.
[2] G. Zimmerman,et al. Platelet-activating Factor Acetylhydrolases* , 1997, The Journal of Biological Chemistry.
[3] M. Nyman,et al. Modeling and control of an electric arc furnace using a feedforward artificial neural network , 1996 .
[4] G. Zimmerman,et al. Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase. , 1996, The Journal of clinical investigation.
[5] Y. Fukuchi,et al. Effects of lung volume on airway resistance during induced constriction in papain-treated rabbits. , 1996, Journal of applied physiology.
[6] K. Kume,et al. A murine platelet-activating factor receptor gene: cloning, chromosomal localization and up-regulation of expression by lipopolysaccharide in peritoneal resident macrophages. , 1996, The Biochemical journal.
[7] S. Masushige,et al. Tissue-specific response of the human platelet-activating factor receptor gene to retinoic acid and thyroid hormone by alternative promoter usage. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[8] Takao Shimizu,et al. Platelet-activating factor receptor: gene expression and signal transduction. , 1995, Biochimica et biophysica acta.
[9] E. Gelfand,et al. Identification of functional platelet-activating factor receptors on human keratinocytes. , 1995, The Journal of investigative dermatology.
[10] H. Narahara,et al. Platelet-activating factor-acetylhydrolase activity in follicular fluid of patients undergoing in vitro fertilization and embryo transfer. , 1995, Fertility and sterility.
[11] G. Imokawa,et al. Endothelin-1 as a new melanogen: coordinated expression of its gene and the tyrosinase gene in UVB-exposed human epidermis. , 1995, The Journal of investigative dermatology.
[12] T. Jacks,et al. A subset of p53-deficient embryos exhibit exencephaly , 1995, Nature Genetics.
[13] R. Frenkel,et al. Platelet-activating factor. Role in fetal lung development and relationship to normal and premature labor. , 1995, Clinics in perinatology.
[14] M. Katsuki,et al. Increased Tyrosine-Phosphorylation of 55-kDa Proteins in -Actin/ Tec Transgenic Mice , 1995 .
[15] J. Miyazaki,et al. Site-specific recombination of a transgene in fertilized eggs by transient expression of Cre recombinase. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[16] S. Kato,et al. Positive and negative regulations of human platelet-activating factor receptor transcript 2 (tissue-type) by estrogen and TGF-beta 1. , 1994, Biochemical and biophysical research communications.
[17] S. Kato,et al. Platelet-Activating Factor (PAF) Positively Auto-Regulates the Expression of Human PAF Receptor Transcript 1 (Leukocyte-Type) Through NF-κB , 1994 .
[18] I. Adcock,et al. Expression of platelet-activating factor receptor mRNA in human and guinea pig lung. , 1994, American journal of respiratory cell and molecular biology.
[19] R. Lefkowitz,et al. Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. , 1994, Science.
[20] H. Bito,et al. Cloning, expression and tissue distribution of rat platelet-activating-factor-receptor cDNA. , 1994, European journal of biochemistry.
[21] E. Nishida,et al. Transfected platelet-activating factor receptor activates mitogen-activated protein (MAP) kinase and MAP kinase kinase in Chinese hamster ovary cells. , 1994, The Journal of biological chemistry.
[22] Kunio Kato,et al. Platelet-activating factor as a potential retrograde messenger in CA1 hippocampal long-term potentiation , 1994, Nature.
[23] Z. Honda,et al. Two distinct signal transduction pathways for the activation of guinea-pig macrophages and neutrophils by endotoxin. , 1993, Biochemical and biophysical research communications.
[24] K. Yamamura,et al. Transgenic mouse lines with ectopic expression of alpha-1,3-galactosyltransferase: production and characteristics. , 1993, Glycobiology.
[25] Y. Yazaki,et al. Overexpression of human lipoprotein lipase in transgenic mice. Resistance to diet-induced hypertriglyceridemia and hypercholesterolemia. , 1993, The Journal of biological chemistry.
[26] M. Olson,et al. Platelet-activating factor: receptors and signal transduction. , 1993, The Biochemical journal.
[27] A. Terano,et al. Two different promoters direct expression of two distinct forms of mRNAs of human platelet‐activating factor receptor , 1993, FEBS letters.
[28] Y. Kurachi,et al. Molecular cloning and characterization of the platelet-activating factor receptor gene expressed in the human heart. , 1992, Biochemical and biophysical research communications.
[29] Takao Shimizu,et al. Endotoxin transduces Ca2+ signaling via platelet‐activating factor receptor , 1992, FEBS letters.
[30] D. Kunz,et al. The human leukocyte platelet-activating factor receptor. cDNA cloning, cell surface expression, and construction of a novel epitope-bearing analog. , 1992, The Journal of biological chemistry.
[31] P. Chomczyński,et al. One-hour downward alkaline capillary transfer for blotting of DNA and RNA. , 1992, Analytical biochemistry.
[32] M. Kawamura,et al. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents. , 1992, The Journal of pharmacology and experimental therapeutics.
[33] C. Page. Mechanisms of hyperresponsiveness: platelet-activating factor. , 1992, The American review of respiratory disease.
[34] Yamamura Ken-ichi,et al. Efficient selection for high-expression transfectants with a novel eukaryotic vector , 1991 .
[35] H. Niwa,et al. Efficient selection for high-expression transfectants with a novel eukaryotic vector. , 1991, Gene.
[36] K. Isobe,et al. Aberrant melanogenesis and melanocytic tumour development in transgenic mice that carry a metallothionein/ret fusion gene. , 1991, The EMBO journal.
[37] H. Bito,et al. Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. , 1991, The Journal of biological chemistry.
[38] E. Prossnitz,et al. Characterization of a human cDNA that encodes a functional receptor for platelet activating factor. , 1991, Biochemical and biophysical research communications.
[39] Takao Shimizu,et al. Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung , 1991, Nature.
[40] L. Dubertret,et al. Production of paf-acether by human epidermal cells. , 1990, The Journal of investigative dermatology.
[41] G. Zimmerman,et al. Platelet-activating Factor , 1991 .
[42] B. Wiggs,et al. Inhibition of antigen-induced airway hyperresponsiveness, but not acute hypoxia nor airway eosinophilia, by an antagonist of platelet-activating factor. , 1990, Journal of immunology.
[43] J. Bates,et al. The low-frequency dependence of respiratory system resistance and elastance in normal dogs. , 1989, Respiration physiology.
[44] J. Sugatani,et al. Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children. , 1988, The Journal of clinical investigation.
[45] R. Halaban,et al. Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes , 1988, The Journal of cell biology.
[46] L. Dubertret,et al. Biosynthesis of paf-acether factor-acether by human skin fibroblasts in vitro. , 1988, Journal of immunology.
[47] J. Drazen,et al. Pulmonary responses to bronchoconstrictor agonists in the mouse. , 1988, Journal of applied physiology.
[48] N. Flavahan,et al. The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity. , 1988, The Journal of allergy and clinical immunology.
[49] P. Braquet,et al. The effect of the selective PAF antagonist BN 52021 on PAF- and antigen-induced bronchial hyper-reactivity and eosinophil accumulation. , 1988, European journal of pharmacology.
[50] N. Voelkel,et al. Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. , 1987, The Journal of clinical investigation.
[51] J. Casals-stenzel,et al. Protective effect of WEB 2086, a novel antagonist of platelet activating factor, in endotoxin shock. , 1987, European journal of pharmacology.
[52] F. Cuss,et al. EFFECTS OF INHALED PLATELET ACTIVATING FACTOR ON PULMONARY FUNCTION AND BRONCHIAL RESPONSIVENESS IN MAN , 1986, The Lancet.
[53] K. Chung,et al. Airway hyperresponsiveness induced by platelet-activating factor: role of thromboxane generation. , 1986, The Journal of pharmacology and experimental therapeutics.
[54] Margaret S. Wu,et al. Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone. , 1985, Biochemical and biophysical research communications.
[55] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[56] R. Lefkowitz,et al. Enhanced Myocardial Function inTransgenic Mice Overexpressing theP2-Adrenergic Receptor , 1994 .
[57] C. O'neill,et al. Actions of platelet activating factor (PAF) on gametes and embryos: clinical aspects. , 1992, Reproduction, fertility, and development.
[58] C. O'neill. Embryo-derived platelet activating factor. , 1992 .
[59] M. Bradl,et al. Melanosis and associated tumors in transgenic mice. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[60] M. Bradl,et al. Malignant melanoma in transgenic mice. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[61] T. Behrens,et al. Control of human T cell proliferation by platelet-activating factor. , 1990, International journal of immunopharmacology.
[62] C. O'neill,et al. Embryo-derived platelet-activating factor. , 1989, Journal of reproduction and fertility. Supplement.
[63] D. Hanahan. Platelet activating factor: a biologically active phosphoglyceride. , 1986, Annual review of biochemistry.
[64] B. Hogan,et al. Manipulating the mouse embryo: A laboratory manual , 1986 .
[65] R. Bowen,et al. Asthmatic children. , 1948, The Journal-lancet.